NCT07887542Completed
Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan
Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan: Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether adding case-manager support to app-connected home blood pressure monitoring improves blood pressure control in adults with hypertension. The main questions it aims to answer are: * Does case-manager surveillance with physician-guided medication adjustment lower office, home, and 24-hour ambulatory blood pressure more than home monitoring with review of readings only at clinic visits? * Does it change how consistently participants measure their blood pressure at home, how their blood pressure medicines are adjusted, and how often side effects are reported? All participants received the same Bluetooth upper-arm blood pressure monitor linked to a smartphone app (OMRON Home BP Monitoring System, HMS). They measured their blood pressure at home in the first week of every month, following the Taiwan "722" schedule: 7 consecutive days, morning and evening, 2 readings each time. Each participant spent 6 months in each of two conditions, in a randomly assigned order: * Case-manager period: case managers reviewed the home readings every month, contacted participants, and arranged earlier clinic visits for medication adjustment when readings met predefined criteria. * Control period: home readings were stored and reviewed by the cardiologist only at scheduled clinic visits. Participants attended clinic visits at the start of the study and at 3, 6, 9, and 12 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 211 (actual)
- First submitted
- 27 Aug 2023
- Start date
- 6 Oct 2022
- Primary completion date
- 21 Oct 2025
- Lead sponsor
- National Taiwan University Hospital Hsin-Chu Branch
- Diseases
- High blood pressure
- NCT number
- NCT07887542
What you commit to
- Study type: Interventional
- Participants enrolled: 211
- From 6 Oct 2022 to the primary completion date, 21 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- End-stage, incurable disease with life expectancy of less than one year.
- Dementia or loss of most self-care ability (ECOG performance status 2 or above).
- Documented cardiac arrhythmia.
- Diagnosed secondary hypertension.
- Acute cardiovascular event within the past six months, including stroke, decompensated heart failure, percutaneous coronary intervention, or coronary artery bypass graft surgery.
Other
- Women who are pregnant, may be pregnant, or are breastfeeding.
- Office blood pressure \>180/110 mmHg.
- Inability to use a smartphone.
Who the study is looking for
- Willing to provide written informed consent.
- Age 18 years or older. Age 18 years or older. (Participants enrolled before approval of protocol version 4 in February 2023 were required to be 20 to 80 years old.)
- Patients receiving antihypertensive medication who have not achieved the treatment target of office blood pressure \<130/80 mmHg, or patients with newly diagnosed hypertension with office systolic blood pressure of 140-180 mmHg and diastolic blood pressure of 90-110 mmHg (or 24-hour ambulatory blood pressure \>130/80 mmHg).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Hsin Chu Branch Coordinator of this site? Confirm its status | Hsinchu | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.